December 14, 2022
PAR-21-341 - Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)
National Cancer Institute (NCI)
This Notice of Change impacts the AIDS Application Due Dates for PAR-21-341, Exploratory Grants in Cancer Control (R21 Clinical Trial Optional).
Part 1. Overview Information, Key Dates
Currently reads:
|
Application Due Dates |
Review and Award Cycles |
||||
|
New |
Renewal / Resubmission / Revision (as allowed) |
AIDS |
Scientific Merit Review |
Advisory Council Review |
Earliest Start Date |
|
June 07, 2022 |
June 07, 2022 |
June 07, 2022 |
November 2022 |
January 2023 |
March 2023 |
|
October 07, 2022 |
October 07, 2022 |
October 07, 2022 |
March 2023 |
May 2023 |
July 2023 |
|
June 07, 2023 |
June 07, 2023 |
June 07, 2023 |
November 2023 |
January 2024 |
March 2024 |
|
October 09, 2023 |
October 09, 2023 |
October 09, 2023 |
March 2024 |
May 2024 |
July 2024 |
|
June 07, 2024 |
June 07, 2024 |
June 07, 2024 |
November 2024 |
January 2025 |
March 2025 |
|
October 08, 2024 |
October 08, 2024 |
October 08, 2024 |
March 2025 |
May 2025 |
July 2025 |
Expiration Date: October 09, 2024
Revised to read (in bold italics):
|
Application Due Dates |
Review and Award Cycles |
||||
|
New |
Renewal / Resubmission / Revision (as allowed) |
AIDS |
Scientific Merit Review |
Advisory Council Review |
Earliest Start Date |
|
June 07, 2022 |
June 07, 2022 |
June 07, 2022 |
November 2022 |
January 2023 |
March 2023 |
|
October 07, 2022 |
October 07, 2022 |
October 07, 2022 |
March 2023 |
May 2023 |
July 2023 |
|
June 07, 2023 |
June 07, 2023 |
June 07, 2023 |
November 2023 |
January 2024 |
March 2024 |
|
October 09, 2023 |
October 09, 2023 |
November 09, 2023 |
March 2024 |
May 2024 |
July 2024 |
|
June 07, 2024 |
June 07, 2024 |
June 07, 2024 |
November 2024 |
January 2025 |
March 2025 |
|
October 08, 2024 |
October 08, 2024 |
November 08, 2024 |
March 2025 |
May 2025 |
July 2025 |
Expiration Date: November 09, 2024
All other aspects of the FOA remain unchanged.
Scientific/Research Contact(s)
Mukesh Verma, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6889
Email: vermam@mail.nih.gov
Peer Review Contact(s)
Examine your eRA Commons account for review assignment and contact information (information appears two weeks after the submission due date).
Financial/Grants Management Contact(s)
Dawn Mitchum
National Cancer Institute (NCI)
Telephone: 240-276-5699
Email: dawn.mitchum@nih.gov
and Human Services (HHS)
